The Italian Institute for Genomic Medicine (IIGM, formerly known as Human Genetics Foundation – Torino) is a private research established by Compagnia di San Paolo, Università degli Studi di Torino and Politecnico di Torino.
In 2016, IIGM starts a transformation and renovation process starting with the appointment of a new President, new advisory boards, and the approval of a renewed Statute, whose changes have been approved be Regione Piemonte in 2017, including the switch of the Foundation name from "Human Genetics Foundation – Torino" to "Italian Institute for Genomic Medicine".
Under the guidance of the new President Prof. Ruggero De Maria Marchiano, IIGM Foundation defines a new strategic plan and new research lines more focused on translational and precision medicine, and bio-medicine.
In 2018, after the appointment of the new Director Prof. Giuseppe Basso, IIGM pursues the renewal programs, that will eventually lead to the establishment of new research units and a remodelled general organization.
IIGM is meant to be a Centre of Excellence for research and high-level education. IIGM follows standards of efficient management and transparency, so to exploit the available resources for research activities and high-level education. IIGM operates with a small management team, in tight collaboration with the Compagnia di S. Paolo Service Centre (Centro Servizi Compagnia di San Paolo-Sistema Torino, CSP-ST) and with Compagnia di San Paolo itself.
During the early years of activity (2010-2017), under the guidance of President Prof. Alberto Piazza and Director Dott. Gianluca Severi, IIGM research programs addressed the fields of human genetics, genomics and epigenomics, that were carried on by the several Research Units within IIGM.
The research projects were funded by grants from Compagnia di San Paolo as well as external funders (AIRC, CE H2020, Veronesi Foundation, Italian "Ministero della Salute"). Investigation topics were immunogenetics, functional genomics, genomic epidemiology, tumour diagnostic/prognostic biomarker research, epigenetic modifications in disease, quantitative biology, and computational neuroscience.
IIGM collaborates with the "Città della Salute" hospital from a decade; in 2017 a new project has started on the "Functional genomics applied to paediatric tumours: from mutations, to function, to therapy", funded by a grant from Compagnia di San Paolo to the "Italian Paediatric Haematology and Oncology Foundation" (Fondazione Italiana Ematologia e Oncologia Pediatrica, FIEOP), and whose research activities mainly take place in IIGM laboratories.